Can the commercial sector capitalize on the merger of high-throughput technology and natural products? Cormac Sheridan investigates.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Establishing a genomic database for the medicinal plants in the Brazilian Pharmacopoeia
Chinese Medicine Open Access 05 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Davies, J. & Ryan, K.S. ACS Chem. Biol. 7, 252–259 (2012).
Zazopoulos, E. et al. Nat. Biotechnol. 21, 187–190 (2003).
McAlpine, J.B. et al. J. Nat. Prod. 68, 493–496 (2005).
Banskota, A.H. et al. J. Antibiot. (Tokyo) 59, 168–176 (2006).
Banskota, A.H. et al. J. Antibiot. (Tokyo) 59, 533–542 (2006).
Moss, S.J. et al. Med. Chem. Commun. doi:10.1039/C1MD00227A (2012).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Recasting natural product research. Nat Biotechnol 30, 385–387 (2012). https://doi.org/10.1038/nbt.2208
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2208
This article is cited by
-
Establishing a genomic database for the medicinal plants in the Brazilian Pharmacopoeia
Chinese Medicine (2021)
-
Nature Biotechnology's academic spinouts of 2017
Nature Biotechnology (2018)
-
The 160K Natural Organism Library, a unique resource for natural products research
Nature Biotechnology (2018)
-
The pharmaceutical industry and natural products: historical status and new trends
Phytochemistry Reviews (2015)
-
Antibiotic resistance–mediated isolation of scaffold-specific natural product producers
Nature Protocols (2014)